Liquiritin ameliorates painful diabetic neuropathy in SD rats by inhibiting NLRP3-MMP-9-mediated reversal of aquaporin-4 polarity in the glymphatic system

Despite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a significant correlation between the expression and distribution of Aquaporin-4 (AQP4) in the spinal glymphatic system and PDN. However, the potential...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 15; p. 1436146
Main Authors Jia, Shuai-Ying, Yin, Wen-Qin, Xu, Wen-Mei, Li, Jiang, Yan, Wei, Lin, Jing-Yan
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 04.09.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Despite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a significant correlation between the expression and distribution of Aquaporin-4 (AQP4) in the spinal glymphatic system and PDN. However, the potential role and mechanism of liquiritin in PDN treatment remain uncertain. This study established a rat model of PDN using a combination of low-dose Streptozotocin (STZ) and a high-fat, high-sugar diet. Rats were treated with liquiritin and MCC950 (an NLRP3 inhibitor). We monitored fasting blood glucose, body weight, and mechanical allodynia periodically. The glymphatic system's clearance function was evaluated using Magnetic Resonance Imaging (MRI), and changes in proteins including NLRP3, MMP-9, and AQP4 were detected through immunofluorescence and Western blot techniques. The rats with painful diabetic neuropathy (PDN) demonstrated several physiological changes, including heightened mechanical allodynia, compromised clearance function within the spinal glymphatic system, altered distribution of AQP4, increased count of activated astrocytes, elevated expression levels of NLRP3 and MMP-9, and decreased expression of AQP4. However, following treatment with liquiritin and MCC950, these rats exhibited notable improvements. Liquiritin may promote the restoration of AQP4 polarity by inhibiting NLRP3 and MMP-9, thereby enhancing the clearance functions of the spinal cord glymphatic system in PDN rats, alleviating the progression of PDN.
AbstractList Despite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a significant correlation between the expression and distribution of Aquaporin-4 (AQP4) in the spinal glymphatic system and PDN. However, the potential role and mechanism of liquiritin in PDN treatment remain uncertain.BackgroundDespite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a significant correlation between the expression and distribution of Aquaporin-4 (AQP4) in the spinal glymphatic system and PDN. However, the potential role and mechanism of liquiritin in PDN treatment remain uncertain.This study established a rat model of PDN using a combination of low-dose Streptozotocin (STZ) and a high-fat, high-sugar diet. Rats were treated with liquiritin and MCC950 (an NLRP3 inhibitor). We monitored fasting blood glucose, body weight, and mechanical allodynia periodically. The glymphatic system's clearance function was evaluated using Magnetic Resonance Imaging (MRI), and changes in proteins including NLRP3, MMP-9, and AQP4 were detected through immunofluorescence and Western blot techniques.MethodsThis study established a rat model of PDN using a combination of low-dose Streptozotocin (STZ) and a high-fat, high-sugar diet. Rats were treated with liquiritin and MCC950 (an NLRP3 inhibitor). We monitored fasting blood glucose, body weight, and mechanical allodynia periodically. The glymphatic system's clearance function was evaluated using Magnetic Resonance Imaging (MRI), and changes in proteins including NLRP3, MMP-9, and AQP4 were detected through immunofluorescence and Western blot techniques.The rats with painful diabetic neuropathy (PDN) demonstrated several physiological changes, including heightened mechanical allodynia, compromised clearance function within the spinal glymphatic system, altered distribution of AQP4, increased count of activated astrocytes, elevated expression levels of NLRP3 and MMP-9, and decreased expression of AQP4. However, following treatment with liquiritin and MCC950, these rats exhibited notable improvements.ResultsThe rats with painful diabetic neuropathy (PDN) demonstrated several physiological changes, including heightened mechanical allodynia, compromised clearance function within the spinal glymphatic system, altered distribution of AQP4, increased count of activated astrocytes, elevated expression levels of NLRP3 and MMP-9, and decreased expression of AQP4. However, following treatment with liquiritin and MCC950, these rats exhibited notable improvements.Liquiritin may promote the restoration of AQP4 polarity by inhibiting NLRP3 and MMP-9, thereby enhancing the clearance functions of the spinal cord glymphatic system in PDN rats, alleviating the progression of PDN.ConclusionLiquiritin may promote the restoration of AQP4 polarity by inhibiting NLRP3 and MMP-9, thereby enhancing the clearance functions of the spinal cord glymphatic system in PDN rats, alleviating the progression of PDN.
Despite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a significant correlation between the expression and distribution of Aquaporin-4 (AQP4) in the spinal glymphatic system and PDN. However, the potential role and mechanism of liquiritin in PDN treatment remain uncertain. This study established a rat model of PDN using a combination of low-dose Streptozotocin (STZ) and a high-fat, high-sugar diet. Rats were treated with liquiritin and MCC950 (an NLRP3 inhibitor). We monitored fasting blood glucose, body weight, and mechanical allodynia periodically. The glymphatic system's clearance function was evaluated using Magnetic Resonance Imaging (MRI), and changes in proteins including NLRP3, MMP-9, and AQP4 were detected through immunofluorescence and Western blot techniques. The rats with painful diabetic neuropathy (PDN) demonstrated several physiological changes, including heightened mechanical allodynia, compromised clearance function within the spinal glymphatic system, altered distribution of AQP4, increased count of activated astrocytes, elevated expression levels of NLRP3 and MMP-9, and decreased expression of AQP4. However, following treatment with liquiritin and MCC950, these rats exhibited notable improvements. Liquiritin may promote the restoration of AQP4 polarity by inhibiting NLRP3 and MMP-9, thereby enhancing the clearance functions of the spinal cord glymphatic system in PDN rats, alleviating the progression of PDN.
Background Despite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a significant correlation between the expression and distribution of Aquaporin-4 (AQP4) in the spinal glymphatic system and PDN. However, the potential role and mechanism of liquiritin in PDN treatment remain uncertain. Methods This study established a rat model of PDN using a combination of low-dose Streptozotocin (STZ) and a high-fat, high-sugar diet. Rats were treated with liquiritin and MCC950 (an NLRP3 inhibitor). We monitored fasting blood glucose, body weight, and mechanical allodynia periodically. The glymphatic system’s clearance function was evaluated using Magnetic Resonance Imaging (MRI), and changes in proteins including NLRP3, MMP-9, and AQP4 were detected through immunofluorescence and Western blot techniques. Results The rats with painful diabetic neuropathy (PDN) demonstrated several physiological changes, including heightened mechanical allodynia, compromised clearance function within the spinal glymphatic system, altered distribution of AQP4, increased count of activated astrocytes, elevated expression levels of NLRP3 and MMP-9, and decreased expression of AQP4. However, following treatment with liquiritin and MCC950, these rats exhibited notable improvements. Conclusion Liquiritin may promote the restoration of AQP4 polarity by inhibiting NLRP3 and MMP-9, thereby enhancing the clearance functions of the spinal cord glymphatic system in PDN rats, alleviating the progression of PDN.
BackgroundDespite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a significant correlation between the expression and distribution of Aquaporin-4 (AQP4) in the spinal glymphatic system and PDN. However, the potential role and mechanism of liquiritin in PDN treatment remain uncertain.MethodsThis study established a rat model of PDN using a combination of low-dose Streptozotocin (STZ) and a high-fat, high-sugar diet. Rats were treated with liquiritin and MCC950 (an NLRP3 inhibitor). We monitored fasting blood glucose, body weight, and mechanical allodynia periodically. The glymphatic system’s clearance function was evaluated using Magnetic Resonance Imaging (MRI), and changes in proteins including NLRP3, MMP-9, and AQP4 were detected through immunofluorescence and Western blot techniques.ResultsThe rats with painful diabetic neuropathy (PDN) demonstrated several physiological changes, including heightened mechanical allodynia, compromised clearance function within the spinal glymphatic system, altered distribution of AQP4, increased count of activated astrocytes, elevated expression levels of NLRP3 and MMP-9, and decreased expression of AQP4. However, following treatment with liquiritin and MCC950, these rats exhibited notable improvements.ConclusionLiquiritin may promote the restoration of AQP4 polarity by inhibiting NLRP3 and MMP-9, thereby enhancing the clearance functions of the spinal cord glymphatic system in PDN rats, alleviating the progression of PDN.
Author Jia, Shuai-Ying
Xu, Wen-Mei
Yin, Wen-Qin
Lin, Jing-Yan
Li, Jiang
Yan, Wei
AuthorAffiliation 1 Department of Anesthesiology , The Affiliated Hospital of North Sichuan Medical College , Nanchong , China
2 Department of Medical Imaging , The Affiliated Hospital of North Sichuan Medical College , Nanchong , China
AuthorAffiliation_xml – name: 2 Department of Medical Imaging , The Affiliated Hospital of North Sichuan Medical College , Nanchong , China
– name: 1 Department of Anesthesiology , The Affiliated Hospital of North Sichuan Medical College , Nanchong , China
Author_xml – sequence: 1
  givenname: Shuai-Ying
  surname: Jia
  fullname: Jia, Shuai-Ying
  organization: Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China
– sequence: 2
  givenname: Wen-Qin
  surname: Yin
  fullname: Yin, Wen-Qin
  organization: Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China
– sequence: 3
  givenname: Wen-Mei
  surname: Xu
  fullname: Xu, Wen-Mei
  organization: Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China
– sequence: 4
  givenname: Jiang
  surname: Li
  fullname: Li, Jiang
  organization: Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China
– sequence: 5
  givenname: Wei
  surname: Yan
  fullname: Yan, Wei
  organization: Department of Medical Imaging, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China
– sequence: 6
  givenname: Jing-Yan
  surname: Lin
  fullname: Lin, Jing-Yan
  organization: Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39295943$$D View this record in MEDLINE/PubMed
BookMark eNpVUstu2zAQFIoUzaP5gR4KHnuRS3IpWTwVRdKmAZw26ONMkPTSZiCJMikF8K_0a0s_GiS88DUzuzuY8-KkDz0WxTtGZwCN_OiGtY4zTrmYMQE1E_Wr4ozVNZSyYfzk2fm0uEzpgeYFUkIt3hSnILmspICz4u_CbyYf_eh7ojtsfYh6xEQG7Xs3tWTptcHRW9LjFMOgx_WWZOiva5JxiZjdbe3Njr8i3xc_76G8u7svZdlhpo64JBEfMSbdkuCI3kx6CNH3pSBDaHWuu5cb10hW7bbLM-1qpW0asXtbvHa6TXh53C-KP1-__L76Vi5-3NxefV6UFio6lhZN5fJwrLFIOXW2dgwaqCznEhw2VfaBajSNMWhZzeas4swx2gDUjQCEi-L2oLsM-kEN0Xc6blXQXu0fQlwpHXNbLaq5cWCNtVTwWogaGjdnlhtOl0uZPdVZ69NBa5hMdsBiP0bdvhB9-dP7tVqFR8WYyB1xyAofjgoxbCZMo-p8sti2uscwJQWM1nOouOQZyg9QG0NKEd1THUbVLiRqHxK1C4k6hiST3j_v8InyPxLwD_N-vTg
Cites_doi 10.1097/wnr.0000000000001880
10.1358/mf.2009.31.4.1362513
10.1177/0271678x16654702
10.7326/m14-0511
10.2337/dc11-1108
10.1016/j.neuropharm.2024.109907
10.1002/jnr.25104
10.1186/s12987-018-0098-1
10.1080/14728222.2017.1398236
10.3389/fneur.2019.01019
10.1177/44.12.8985139
10.1016/j.biopha.2017.07.167
10.1016/j.jneuroim.2020.577457
10.1016/j.neulet.2023.137164
10.1016/j.heliyon.2023.e13290
10.1016/b978-0-12-386043-9.00001-3
10.3390/biomedicines10092261
10.1038/s41419-020-03178-2
10.1097/shk.0000000000001832
10.1038/nrn1870
10.3389/fphar.2019.01522
10.1016/j.expneurol.2016.05.003
10.1002/dmrr.1225
10.1016/j.neulet.2021.136049
10.1016/j.fitote.2020.104803
10.1007/s00429-013-0629-0
10.1016/j.vascn.2012.04.006
10.3389/fphar.2022.944386
10.1093/brain/awad274
10.1002/ana.24271
10.7554/eLife.40070
10.1016/j.lfs.2021.120062
10.3892/mmr.2017.6786
10.1002/jmri.25168
10.1016/j.jare.2023.03.004
10.1016/j.jneuroim.2013.06.005
10.1016/j.neuroscience.2012.06.002
10.1523/jneurosci.3020-14.2014
10.1186/1742-2094-7-36
10.2147/dddt.S386805
10.1126/scitranslmed.3003748
10.3389/fnana.2020.00017
10.1016/j.diabres.2022.109806
10.1186/s13041-014-0069-7
10.1038/nrn3468
10.1016/j.diabres.2021.109119
10.3390/ijms17101413
10.3389/fnins.2022.926128
10.1007/s11064-015-1581-6
10.3171/2022.4.Jns212945
10.3389/fnmol.2017.00395
10.3389/fphar.2020.00436
10.1111/pedi.13033
10.1172/jci67677
10.1016/j.mcn.2012.02.002
10.1016/j.xphs.2022.03.021
10.1016/j.neuroscience.2016.03.055
10.1002/cpz1.78
10.1083/jcb.153.3.543
10.1523/jneurosci.17-01-00171.1997
10.1371/journal.pone.0163909
10.3892/ijmm.2018.3720
10.1016/j.lfs.2017.05.028
10.1523/jneurosci.1592-13.2013
10.3389/fncel.2019.00572
10.1038/72256
10.1016/0165-0270(94)90144-9
10.1016/j.steroids.2007.12.018
10.1016/j.intimp.2022.108800
10.1186/s12906-016-1048-6
10.3389/fphar.2021.605814
10.7554/eLife.82232
10.3389/fphys.2020.01016
10.1016/j.taap.2021.115468
10.1038/nn.4288
10.3310/rxuo6757
10.1016/j.intimp.2021.108283
10.1002/glia.22319
10.1136/bmjdrc-2020-001847
10.1001/jamaneurol.2016.4370
10.1523/jneurosci.3390-16.2017
10.1038/ncomms4413
10.1007/s13300-019-00695-y
10.1038/s41417-022-00582-y
10.1371/journal.pone.0107022
10.1038/s41419-019-1761-4
10.3389/fphar.2023.1128496
10.1007/s00467-006-0411-0
10.1016/j.lfs.2020.117638
10.1016/j.lfs.2019.02.024
10.1097/j.pain.0000000000001744
10.1007/s00401-009-0558-4
10.3389/fphar.2021.719758
10.1016/j.jcjd.2020.11.011
ContentType Journal Article
Copyright Copyright © 2024 Jia, Yin, Xu, Li, Yan and Lin.
Copyright © 2024 Jia, Yin, Xu, Li, Yan and Lin. 2024 Jia, Yin, Xu, Li, Yan and Lin
Copyright_xml – notice: Copyright © 2024 Jia, Yin, Xu, Li, Yan and Lin.
– notice: Copyright © 2024 Jia, Yin, Xu, Li, Yan and Lin. 2024 Jia, Yin, Xu, Li, Yan and Lin
DBID NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fphar.2024.1436146
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Jia et al
EISSN 1663-9812
ExternalDocumentID oai_doaj_org_article_7bf3cbcc042644638f71c2b20dd9392a
10_3389_fphar_2024_1436146
39295943
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
IAO
IEA
IHR
IHW
IPNFZ
KQ8
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
RIG
RNS
RPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c350t-ceb5f00018ce020fc6f13835c2293fe856630aeb8bbec16171521f108336843e3
IEDL.DBID RPM
ISSN 1663-9812
IngestDate Tue Oct 22 15:15:21 EDT 2024
Thu Sep 19 05:32:17 EDT 2024
Sat Oct 26 04:03:12 EDT 2024
Thu Sep 26 20:27:18 EDT 2024
Sat Nov 02 12:19:13 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords aquaporin-4
liquiritin
matrix metalloproteinase-9
glymphatic system
painful diabetic neuropathy
Language English
License Copyright © 2024 Jia, Yin, Xu, Li, Yan and Lin.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c350t-ceb5f00018ce020fc6f13835c2293fe856630aeb8bbec16171521f108336843e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Idris Long, University of Science Malaysia (USM), Malaysia
Edited by: Tzer-Bin Lin, Taipei Medical University, Taiwan
Reviewed by: Bin-Nan Wu, Kaohsiung Medical University, Taiwan
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11408323/
PMID 39295943
PQID 3106735292
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_7bf3cbcc042644638f71c2b20dd9392a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11408323
proquest_miscellaneous_3106735292
crossref_primary_10_3389_fphar_2024_1436146
pubmed_primary_39295943
PublicationCentury 2000
PublicationDate 2024-09-04
PublicationDateYYYYMMDD 2024-09-04
PublicationDate_xml – month: 09
  year: 2024
  text: 2024-09-04
  day: 04
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in pharmacology
PublicationTitleAlternate Front Pharmacol
PublicationYear 2024
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References An (B4) 2021; 9
Hubbard (B22) 2016; 283
Cheng (B9) 2021; 149
Das (B11) 2012; 220
Yin (B86) 2019; 13
Han (B20) 2022; 16
Paschou (B48) 2019; 10
Peng (B49) 2020; 11
Wang (B74); 111
Li (B33) 2018; 42
Manley (B40) 2000; 6
Aronson (B5) 2021; 45
Xian (B79) 2021; 351
Griebeler (B16) 2014; 161
Jessen (B28) 2015; 40
Gylfadottir (B18) 2020; 161
Papadopoulos (B46) 2007; 22
Tesfaye (B64) 2011; 27
Troili (B67) 2020; 14
Zheng (B93); 12
Zhang (B91) 2021; 12
Liu (B37) 2024; 147
Tesfaye (B63) 2022; 26
Thomas (B65) 2016; 11
Yang (B83) 2012; 49
Zhang (B89); 95
Verkman (B68) 2017; 21
Zheng (B94); 416
Amutha (B3) 2021; 22
Wang (B69); 16
Deng (B12) 2014; 9
Aman (B2) 2016; 16
Gomolka (B15) 2023; 12
Kress (B31) 2014; 76
Sun (B59) 2019; 10
Xu (B80) 2023; 34
Buccellato (B6) 2022; 10
Li (B34) 2014; 7
Islam (B27) 2009; 31
Chaplan (B7) 1994; 53
Dai (B10) 2017; 16
Luo (B39) 2019; 10
Wang (B70); 100
Zhang (B90) 2022; 186
Iliff (B26); 33
Iliff (B25) 2012; 4
Wolburg (B77) 2011; 287
Nirogi (B45) 2012; 66
Yao (B85) 2014; 5
Furman (B13) 2021; 1
Nielsen (B44) 1997; 17
Ropero (B51) 2008; 73
Si (B55) 2024; 56
Talbot (B61) 2010; 7
Wang (B71) 2020; 251
Chen (B8) 2022; 13
Iliff (B23) 2014; 34
Liu (B35) 2018; 15
Shang (B54) 2023; 801
Wolburg-Buchholz (B78) 2009; 118
Tang (B62) 2016; 17
Sweeney (B60) 2016; 19
Sun (B58) 2022; 183
Yamaguchi (B81) 2023; 138
Yan (B82) 2016; 326
Ni (B43) 2020; 11
Hellström (B21) 2001; 153
Wang (B75); 30
Starobova (B56) 2020; 11
Abbott (B1) 2011; 34
Zeppenfeld (B87) 2017; 74
Haj-Yasein (B19) 2012; 60
Zychowska (B95) 2013; 262
Wang (B73); 9
Jiang (B29) 2017; 37
Schain (B52) 2017; 37
Liu (B36) 2021; 286
Iliff (B24); 123
Su (B57) 2019; 10
Zhang (B88); 10
Zheng (B92) 2022; 109
Ljubimov (B38) 1996; 44
Meyers (B42) 2016; 44
Papadopoulos (B47) 2013; 14
Gundersen (B17) 2014; 219
Gao (B14) 2019; 221
Jing (B30) 2014; 127
Li (B32) 2024; 250
Tokhi (B66) 2023; 14
Yang (B84) 2021; 101
Wang (B72) 2021; 759
Mestre (B41) 2018; 7
Ren (B50) 2021; 56
Seifert (B53) 2006; 7
Wei (B76) 2017; 182
References_xml – volume: 34
  start-page: 190
  year: 2023
  ident: B80
  article-title: Restoration of aquaporin-4 polarization in the spinal glymphatic system by metformin in rats with painful diabetic neuropathy
  publication-title: Neuroreport
  doi: 10.1097/wnr.0000000000001880
  contributor:
    fullname: Xu
– volume: 31
  start-page: 249
  year: 2009
  ident: B27
  article-title: Experimental rodent models of type 2 diabetes: a review
  publication-title: Methods Find. Exp. Clin. Pharmacol.
  doi: 10.1358/mf.2009.31.4.1362513
  contributor:
    fullname: Islam
– volume: 37
  start-page: 1326
  year: 2017
  ident: B29
  article-title: Impairment of the glymphatic system after diabetes
  publication-title: J. Cereb. Blood Flow. Metab.
  doi: 10.1177/0271678x16654702
  contributor:
    fullname: Jiang
– volume: 161
  start-page: 639
  year: 2014
  ident: B16
  article-title: Pharmacologic interventions for painful diabetic neuropathy: an umbrella systematic review and comparative effectiveness network meta-analysis
  publication-title: Ann. Intern Med.
  doi: 10.7326/m14-0511
  contributor:
    fullname: Griebeler
– volume: 34
  start-page: 2220
  year: 2011
  ident: B1
  article-title: Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K
  publication-title: Diabetes Care
  doi: 10.2337/dc11-1108
  contributor:
    fullname: Abbott
– volume: 250
  start-page: 109907
  year: 2024
  ident: B32
  article-title: Ginkgolide B can alleviate spinal cord glymphatic system dysfunction and provide neuroprotection in painful diabetic neuropathy rats by inhibiting matrix metalloproteinase-9
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2024.109907
  contributor:
    fullname: Li
– volume: 100
  start-page: 1908
  ident: B70
  article-title: Plasticity of the spinal glymphatic system in male SD rats with painful diabetic neuropathy induced by type 2 diabetes mellitus
  publication-title: J. Neurosci. Res.
  doi: 10.1002/jnr.25104
  contributor:
    fullname: Wang
– volume: 15
  start-page: 13
  year: 2018
  ident: B35
  article-title: Fluid outflow in the rat spinal cord: the role of perivascular and paravascular pathways
  publication-title: Fluids Barriers CNS
  doi: 10.1186/s12987-018-0098-1
  contributor:
    fullname: Liu
– volume: 127
  start-page: 2808
  year: 2014
  ident: B30
  article-title: Microvascular protective role of pericytes in melatonin-treated spinal cord injury in the C57BL/6 mice
  publication-title: Chin. Med. J. Engl.
  contributor:
    fullname: Jing
– volume: 21
  start-page: 1161
  year: 2017
  ident: B68
  article-title: The aquaporin-4 water channel as a potential drug target in neurological disorders
  publication-title: Expert Opin. Ther. Targets
  doi: 10.1080/14728222.2017.1398236
  contributor:
    fullname: Verkman
– volume: 10
  start-page: 1019
  year: 2019
  ident: B39
  article-title: Elevated levels of NLRP3 in cerebrospinal fluid of patients with autoimmune GFAP astrocytopathy
  publication-title: Front. Neurol.
  doi: 10.3389/fneur.2019.01019
  contributor:
    fullname: Luo
– volume: 44
  start-page: 1469
  year: 1996
  ident: B38
  article-title: Basement membrane abnormalities in human eyes with diabetic retinopathy
  publication-title: J. Histochem Cytochem
  doi: 10.1177/44.12.8985139
  contributor:
    fullname: Ljubimov
– volume: 95
  start-page: 186
  ident: B89
  article-title: Neuroprotective effect of liquiritin against neuropathic pain induced by chronic constriction injury of the sciatic nerve in mice
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2017.07.167
  contributor:
    fullname: Zhang
– volume: 351
  start-page: 577457
  year: 2021
  ident: B79
  article-title: LncRNA NEAT1/miR-128-3p/AQP4 axis regulating spinal cord injury-induced neuropathic pain progression
  publication-title: J. Neuroimmunol.
  doi: 10.1016/j.jneuroim.2020.577457
  contributor:
    fullname: Xian
– volume: 801
  start-page: 137164
  year: 2023
  ident: B54
  article-title: Sevoflurane preconditioning improves neuroinflammation in cerebral ischemia/reperfusion induced rats through ROS-NLRP3 pathway
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2023.137164
  contributor:
    fullname: Shang
– volume: 9
  start-page: e13290
  ident: B73
  article-title: Liquiritin inhibits MRGPRX2-mediated pseudo-allergy through the PI3K/AKT and PLCγ signaling pathways
  publication-title: Heliyon
  doi: 10.1016/j.heliyon.2023.e13290
  contributor:
    fullname: Wang
– volume: 287
  start-page: 1
  year: 2011
  ident: B77
  article-title: Structure and functions of aquaporin-4-based orthogonal arrays of particles
  publication-title: Int. Rev. Cell Mol. Biol.
  doi: 10.1016/b978-0-12-386043-9.00001-3
  contributor:
    fullname: Wolburg
– volume: 10
  start-page: 2261
  year: 2022
  ident: B6
  article-title: The role of glymphatic system in Alzheimer's and Parkinson's disease pathogenesis
  publication-title: Biomedicines
  doi: 10.3390/biomedicines10092261
  contributor:
    fullname: Buccellato
– volume: 11
  start-page: 978
  year: 2020
  ident: B49
  article-title: Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-020-03178-2
  contributor:
    fullname: Peng
– volume: 56
  start-page: 840
  year: 2021
  ident: B50
  article-title: NLRP3 inflammasome mediates neurodegeneration in rats with chronic neuropathic pain
  publication-title: Shock
  doi: 10.1097/shk.0000000000001832
  contributor:
    fullname: Ren
– volume: 7
  start-page: 194
  year: 2006
  ident: B53
  article-title: Astrocyte dysfunction in neurological disorders: a molecular perspective
  publication-title: Nat. Rev. Neurosci.
  doi: 10.1038/nrn1870
  contributor:
    fullname: Seifert
– volume: 10
  start-page: 1522
  year: 2019
  ident: B57
  article-title: Inhibitory effects of columbianadin on nociceptive behaviors in a neuropathic pain model, and on voltage-gated calcium currents in dorsal root ganglion neurons in mice
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2019.01522
  contributor:
    fullname: Su
– volume: 283
  start-page: 85
  year: 2016
  ident: B22
  article-title: Regulation of astrocyte glutamate transporter-1 (GLT1) and aquaporin-4 (AQP4) expression in a model of epilepsy
  publication-title: Exp. Neurol.
  doi: 10.1016/j.expneurol.2016.05.003
  contributor:
    fullname: Hubbard
– volume: 27
  start-page: 629
  year: 2011
  ident: B64
  article-title: Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management
  publication-title: Diabetes Metab. Res. Rev.
  doi: 10.1002/dmrr.1225
  contributor:
    fullname: Tesfaye
– volume: 759
  start-page: 136049
  year: 2021
  ident: B72
  article-title: Enterovirus 71 infection induced Aquaporin-4 depolarization by increasing matrix metalloproteinase-9 activity
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2021.136049
  contributor:
    fullname: Wang
– volume: 149
  start-page: 104803
  year: 2021
  ident: B9
  article-title: Recent advances in chemical analysis of licorice (Gan-Cao)
  publication-title: Fitoterapia
  doi: 10.1016/j.fitote.2020.104803
  contributor:
    fullname: Cheng
– volume: 219
  start-page: 2181
  year: 2014
  ident: B17
  article-title: Evidence that pericytes regulate aquaporin-4 polarization in mouse cortical astrocytes
  publication-title: Brain Struct. Funct.
  doi: 10.1007/s00429-013-0629-0
  contributor:
    fullname: Gundersen
– volume: 66
  start-page: 8
  year: 2012
  ident: B45
  article-title: Comparison of manual and automated filaments for evaluation of neuropathic pain behavior in rats
  publication-title: J. Pharmacol. Toxicol. Methods
  doi: 10.1016/j.vascn.2012.04.006
  contributor:
    fullname: Nirogi
– volume: 13
  start-page: 944386
  year: 2022
  ident: B8
  article-title: Combination of paeoniflorin and liquiritin alleviates neuropathic pain by lipid metabolism and calcium signaling coordination
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2022.944386
  contributor:
    fullname: Chen
– volume: 147
  start-page: 100
  year: 2024
  ident: B37
  article-title: Glymphatic dysfunction in patients with early-stage amyotrophic lateral sclerosis
  publication-title: Brain
  doi: 10.1093/brain/awad274
  contributor:
    fullname: Liu
– volume: 76
  start-page: 845
  year: 2014
  ident: B31
  article-title: Impairment of paravascular clearance pathways in the aging brain
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.24271
  contributor:
    fullname: Kress
– volume: 7
  start-page: e40070
  year: 2018
  ident: B41
  article-title: Aquaporin-4-dependent glymphatic solute transport in the rodent brain
  publication-title: Elife
  doi: 10.7554/eLife.40070
  contributor:
    fullname: Mestre
– volume: 286
  start-page: 120062
  year: 2021
  ident: B36
  article-title: A new mouse model of type 2 diabetes mellitus established through combination of high-fat diet, streptozotocin and glucocorticoid
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2021.120062
  contributor:
    fullname: Liu
– volume: 16
  start-page: 1739
  year: 2017
  ident: B10
  article-title: Alterations in AQP4 expression and polarization in the course of motor neuron degeneration in SOD1G93A mice
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr.2017.6786
  contributor:
    fullname: Dai
– volume: 44
  start-page: 296
  year: 2016
  ident: B42
  article-title: Does hydration status affect MRI measures of brain volume or water content?
  publication-title: J. Magn. Reson Imaging
  doi: 10.1002/jmri.25168
  contributor:
    fullname: Meyers
– volume: 56
  start-page: 125
  year: 2024
  ident: B55
  article-title: Matrix metalloproteinase-9 inhibition prevents aquaporin-4 depolarization-mediated glymphatic dysfunction in Parkinson's disease
  publication-title: J. Adv. Res.
  doi: 10.1016/j.jare.2023.03.004
  contributor:
    fullname: Si
– volume: 262
  start-page: 35
  year: 2013
  ident: B95
  article-title: Minocycline influences the anti-inflammatory interleukins and enhances the effectiveness of morphine under mice diabetic neuropathy
  publication-title: J. Neuroimmunol.
  doi: 10.1016/j.jneuroim.2013.06.005
  contributor:
    fullname: Zychowska
– volume: 220
  start-page: 237
  year: 2012
  ident: B11
  article-title: Hippocampal tissue of patients with refractory temporal lobe epilepsy is associated with astrocyte activation, inflammation, and altered expression of channels and receptors
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2012.06.002
  contributor:
    fullname: Das
– volume: 34
  start-page: 16180
  year: 2014
  ident: B23
  article-title: Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury
  publication-title: J. Neurosci.
  doi: 10.1523/jneurosci.3020-14.2014
  contributor:
    fullname: Iliff
– volume: 7
  start-page: 36
  year: 2010
  ident: B61
  article-title: Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy
  publication-title: J. Neuroinflammation
  doi: 10.1186/1742-2094-7-36
  contributor:
    fullname: Talbot
– volume: 16
  start-page: 4111
  year: 2022
  ident: B20
  article-title: Liquiritin protects against cardiac fibrosis after myocardial infarction by inhibiting CCL5 expression and the NF-κB signaling pathway
  publication-title: Drug Des. Devel Ther.
  doi: 10.2147/dddt.S386805
  contributor:
    fullname: Han
– volume: 4
  start-page: 147ra111
  year: 2012
  ident: B25
  article-title: A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.3003748
  contributor:
    fullname: Iliff
– volume: 14
  start-page: 17
  year: 2020
  ident: B67
  article-title: Perivascular unit: this must Be the place. The anatomical crossroad between the immune, vascular and nervous system
  publication-title: Front. Neuroanat.
  doi: 10.3389/fnana.2020.00017
  contributor:
    fullname: Troili
– volume: 186
  start-page: 109806
  year: 2022
  ident: B90
  article-title: Glucagon-like peptide-1 receptor agonist attenuates diabetic neuropathic pain via inhibition of NOD-like receptor protein 3 inflammasome in brain microglia
  publication-title: Diabetes Res. Clin. Pract.
  doi: 10.1016/j.diabres.2022.109806
  contributor:
    fullname: Zhang
– volume: 7
  start-page: 69
  year: 2014
  ident: B34
  article-title: Sevoflurane preconditioning ameliorates neuronal deficits by inhibiting microglial MMP-9 expression after spinal cord ischemia/reperfusion in rats
  publication-title: Mol. Brain
  doi: 10.1186/s13041-014-0069-7
  contributor:
    fullname: Li
– volume: 14
  start-page: 265
  year: 2013
  ident: B47
  article-title: Aquaporin water channels in the nervous system
  publication-title: Nat. Rev. Neurosci.
  doi: 10.1038/nrn3468
  contributor:
    fullname: Papadopoulos
– volume: 183
  start-page: 109119
  year: 2022
  ident: B58
  article-title: IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
  publication-title: Diabetes Res. Clin. Pract.
  doi: 10.1016/j.diabres.2021.109119
  contributor:
    fullname: Sun
– volume: 17
  start-page: 1413
  year: 2016
  ident: B62
  article-title: Aquaporin-4: a potential therapeutic target for cerebral edema
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms17101413
  contributor:
    fullname: Tang
– volume: 16
  start-page: 926128
  ident: B69
  article-title: β-Hydroxybutyrate attenuates painful diabetic neuropathy via restoration of the aquaporin-4 polarity in the spinal glymphatic system
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2022.926128
  contributor:
    fullname: Wang
– volume: 40
  start-page: 2583
  year: 2015
  ident: B28
  article-title: The glymphatic system: a beginner's guide
  publication-title: Neurochem. Res.
  doi: 10.1007/s11064-015-1581-6
  contributor:
    fullname: Jessen
– volume: 138
  start-page: 191
  year: 2023
  ident: B81
  article-title: Activation of the NLRP3/IL-1β/MMP-9 pathway and intracranial aneurysm rupture associated with the depletion of ERα and Sirt1 in oophorectomized rats
  publication-title: J. Neurosurg.
  doi: 10.3171/2022.4.Jns212945
  contributor:
    fullname: Yamaguchi
– volume: 10
  start-page: 395
  ident: B88
  article-title: Intermittent fasting protects against Alzheimer's disease possible through restoring aquaporin-4 polarity
  publication-title: Front. Mol. Neurosci.
  doi: 10.3389/fnmol.2017.00395
  contributor:
    fullname: Zhang
– volume: 11
  start-page: 436
  year: 2020
  ident: B43
  article-title: Liquiritin alleviates pain through inhibiting CXCL1/CXCR2 signaling pathway in bone cancer pain rat
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2020.00436
  contributor:
    fullname: Ni
– volume: 22
  start-page: 67
  year: 2021
  ident: B3
  article-title: Clinical profile and incidence of microvascular complications of childhood and adolescent onset type 1 and type 2 diabetes seen at a tertiary diabetes center in India
  publication-title: Pediatr. Diabetes
  doi: 10.1111/pedi.13033
  contributor:
    fullname: Amutha
– volume: 123
  start-page: 1299
  ident: B24
  article-title: Brain-wide pathway for waste clearance captured by contrast-enhanced MRI
  publication-title: J. Clin. Invest.
  doi: 10.1172/jci67677
  contributor:
    fullname: Iliff
– volume: 49
  start-page: 406
  year: 2012
  ident: B83
  article-title: Aquaporin-4 mediates astrocyte response to β-amyloid
  publication-title: Mol. Cell Neurosci.
  doi: 10.1016/j.mcn.2012.02.002
  contributor:
    fullname: Yang
– volume: 111
  start-page: 2083
  ident: B74
  article-title: Liquiritin-hydroxypropyl-beta-cyclodextrin inclusion complex: preparation, characterization, bioavailability and antitumor activity evaluation
  publication-title: J. Pharm. Sci.
  doi: 10.1016/j.xphs.2022.03.021
  contributor:
    fullname: Wang
– volume: 326
  start-page: 141
  year: 2016
  ident: B82
  article-title: β-Dystroglycan cleavage by matrix metalloproteinase-2/-9 disturbs aquaporin-4 polarization and influences brain edema in acute cerebral ischemia
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2016.03.055
  contributor:
    fullname: Yan
– volume: 1
  start-page: e78
  year: 2021
  ident: B13
  article-title: Streptozotocin-induced diabetic models in mice and rats
  publication-title: Curr. Protoc.
  doi: 10.1002/cpz1.78
  contributor:
    fullname: Furman
– volume: 153
  start-page: 543
  year: 2001
  ident: B21
  article-title: Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis
  publication-title: J. Cell Biol.
  doi: 10.1083/jcb.153.3.543
  contributor:
    fullname: Hellström
– volume: 17
  start-page: 171
  year: 1997
  ident: B44
  article-title: Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain
  publication-title: J. Neurosci.
  doi: 10.1523/jneurosci.17-01-00171.1997
  contributor:
    fullname: Nielsen
– volume: 11
  start-page: e0163909
  year: 2016
  ident: B65
  article-title: Efficacy of intrathecal morphine in a model of surgical pain in rats
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0163909
  contributor:
    fullname: Thomas
– volume: 42
  start-page: 1445
  year: 2018
  ident: B33
  article-title: Liquiritin suppresses UVB-induced skin injury through prevention of inflammation, oxidative stress and apoptosis through the TLR4/MyD88/NF-κB and MAPK/caspase signaling pathways
  publication-title: Int. J. Mol. Med.
  doi: 10.3892/ijmm.2018.3720
  contributor:
    fullname: Li
– volume: 182
  start-page: 29
  year: 2017
  ident: B76
  article-title: The pathway of subarachnoid CSF moving into the spinal parenchyma and the role of astrocytic aquaporin-4 in this process
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2017.05.028
  contributor:
    fullname: Wei
– volume: 33
  start-page: 18190
  ident: B26
  article-title: Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain
  publication-title: J. Neurosci.
  doi: 10.1523/jneurosci.1592-13.2013
  contributor:
    fullname: Iliff
– volume: 13
  start-page: 572
  year: 2019
  ident: B86
  article-title: Dynamic balance of microglia and astrocytes involved in the remyelinating effect of ginkgolide B
  publication-title: Front. Cell Neurosci.
  doi: 10.3389/fncel.2019.00572
  contributor:
    fullname: Yin
– volume: 6
  start-page: 159
  year: 2000
  ident: B40
  article-title: Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke
  publication-title: Nat. Med.
  doi: 10.1038/72256
  contributor:
    fullname: Manley
– volume: 53
  start-page: 55
  year: 1994
  ident: B7
  article-title: Quantitative assessment of tactile allodynia in the rat paw
  publication-title: J. Neurosci. Methods
  doi: 10.1016/0165-0270(94)90144-9
  contributor:
    fullname: Chaplan
– volume: 73
  start-page: 874
  year: 2008
  ident: B51
  article-title: The role of estrogen receptors in the control of energy and glucose homeostasis
  publication-title: Steroids
  doi: 10.1016/j.steroids.2007.12.018
  contributor:
    fullname: Ropero
– volume: 109
  start-page: 108800
  year: 2022
  ident: B92
  article-title: Sevoflurane suppresses NLRP3 inflammasome-mediated pyroptotic cell death to attenuate lipopolysaccharide-induced acute lung injury through inducing GSK-3β phosphorylation and activation
  publication-title: Int. Immunopharmacol.
  doi: 10.1016/j.intimp.2022.108800
  contributor:
    fullname: Zheng
– volume: 16
  start-page: 77
  year: 2016
  ident: B2
  article-title: Passiflora incarnata attenuation of neuropathic allodynia and vulvodynia apropos GABA-ergic and opioidergic antinociceptive and behavioural mechanisms
  publication-title: BMC Complement. Altern. Med.
  doi: 10.1186/s12906-016-1048-6
  contributor:
    fullname: Aman
– volume: 12
  start-page: 605814
  ident: B93
  article-title: Xueshuantong improves functions of lymphatic ducts and modulates inflammatory responses in Alzheimer's disease mice
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2021.605814
  contributor:
    fullname: Zheng
– volume: 12
  start-page: e82232
  year: 2023
  ident: B15
  article-title: Loss of aquaporin-4 results in glymphatic system dysfunction via brain-wide interstitial fluid stagnation
  publication-title: Elife
  doi: 10.7554/eLife.82232
  contributor:
    fullname: Gomolka
– volume: 11
  start-page: 1016
  year: 2020
  ident: B56
  article-title: The NLRP3 inflammasome: role and therapeutic potential in pain treatment
  publication-title: Front. Physiol.
  doi: 10.3389/fphys.2020.01016
  contributor:
    fullname: Starobova
– volume: 416
  start-page: 115468
  ident: B94
  article-title: Salidroside alleviates diabetic neuropathic pain through regulation of the AMPK-NLRP3 inflammasome axis
  publication-title: Toxicol. Appl. Pharmacol.
  doi: 10.1016/j.taap.2021.115468
  contributor:
    fullname: Zheng
– volume: 19
  start-page: 771
  year: 2016
  ident: B60
  article-title: Pericytes of the neurovascular unit: key functions and signaling pathways
  publication-title: Nat. Neurosci.
  doi: 10.1038/nn.4288
  contributor:
    fullname: Sweeney
– volume: 26
  start-page: 1
  year: 2022
  ident: B63
  article-title: Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT
  publication-title: Health Technol. Assess.
  doi: 10.3310/rxuo6757
  contributor:
    fullname: Tesfaye
– volume: 101
  start-page: 108283
  year: 2021
  ident: B84
  article-title: Liquiritin reduces lipopolysaccharide-aroused HaCaT cell inflammation damage via regulation of microRNA-31/MyD88
  publication-title: Int. Immunopharmacol.
  doi: 10.1016/j.intimp.2021.108283
  contributor:
    fullname: Yang
– volume: 60
  start-page: 867
  year: 2012
  ident: B19
  article-title: Aquaporin-4 regulates extracellular space volume dynamics during high-frequency synaptic stimulation: a gene deletion study in mouse hippocampus
  publication-title: Glia
  doi: 10.1002/glia.22319
  contributor:
    fullname: Haj-Yasein
– volume: 9
  start-page: e001847
  year: 2021
  ident: B4
  article-title: Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes
  publication-title: BMJ Open Diabetes Res. Care
  doi: 10.1136/bmjdrc-2020-001847
  contributor:
    fullname: An
– volume: 74
  start-page: 91
  year: 2017
  ident: B87
  article-title: Association of perivascular localization of aquaporin-4 with cognition and alzheimer disease in aging brains
  publication-title: JAMA Neurol.
  doi: 10.1001/jamaneurol.2016.4370
  contributor:
    fullname: Zeppenfeld
– volume: 37
  start-page: 2904
  year: 2017
  ident: B52
  article-title: Cortical spreading depression closes paravascular space and impairs glymphatic flow: implications for migraine headache
  publication-title: J. Neurosci.
  doi: 10.1523/jneurosci.3390-16.2017
  contributor:
    fullname: Schain
– volume: 5
  start-page: 3413
  year: 2014
  ident: B85
  article-title: Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms4413
  contributor:
    fullname: Yao
– volume: 10
  start-page: 2313
  year: 2019
  ident: B48
  article-title: Type 2 diabetes mellitus and menopausal hormone therapy: an update
  publication-title: Diabetes Ther.
  doi: 10.1007/s13300-019-00695-y
  contributor:
    fullname: Paschou
– volume: 30
  start-page: 716
  ident: B75
  article-title: Single-cell RNA sequencing reveals changes in glioma-associated macrophage polarization and cellular states of malignant gliomas with high AQP4 expression
  publication-title: Cancer Gene Ther.
  doi: 10.1038/s41417-022-00582-y
  contributor:
    fullname: Wang
– volume: 9
  start-page: e107022
  year: 2014
  ident: B12
  article-title: Expression of aquaporin 4 and breakdown of the blood-brain barrier after hypoglycemia-induced brain edema in rats
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0107022
  contributor:
    fullname: Deng
– volume: 10
  start-page: 542
  year: 2019
  ident: B59
  article-title: Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-019-1761-4
  contributor:
    fullname: Sun
– volume: 14
  start-page: 1128496
  year: 2023
  ident: B66
  article-title: Effects of 1-methyl-1, 2, 3, 4-tetrahydroisoquinoline on a diabetic neuropathic pain model
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2023.1128496
  contributor:
    fullname: Tokhi
– volume: 22
  start-page: 778
  year: 2007
  ident: B46
  article-title: Aquaporin-4 and brain edema
  publication-title: Pediatr. Nephrol.
  doi: 10.1007/s00467-006-0411-0
  contributor:
    fullname: Papadopoulos
– volume: 251
  start-page: 117638
  year: 2020
  ident: B71
  article-title: Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2020.117638
  contributor:
    fullname: Wang
– volume: 221
  start-page: 143
  year: 2019
  ident: B14
  article-title: Sevoflurane enhanced the clearance of Aβ1-40 in hippocampus under surgery via up-regulating AQP-4 expression in astrocyte
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2019.02.024
  contributor:
    fullname: Gao
– volume: 161
  start-page: 574
  year: 2020
  ident: B18
  article-title: Diabetic polyneuropathy and pain, prevalence, and patient characteristics: a cross-sectional questionnaire study of 5,514 patients with recently diagnosed type 2 diabetes
  publication-title: Pain
  doi: 10.1097/j.pain.0000000000001744
  contributor:
    fullname: Gylfadottir
– volume: 118
  start-page: 219
  year: 2009
  ident: B78
  article-title: Loss of astrocyte polarity marks blood-brain barrier impairment during experimental autoimmune encephalomyelitis
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-009-0558-4
  contributor:
    fullname: Wolburg-Buchholz
– volume: 12
  start-page: 719758
  year: 2021
  ident: B91
  article-title: Traditional uses, pharmacological effects, and molecular mechanisms of licorice in potential therapy of COVID-19
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2021.719758
  contributor:
    fullname: Zhang
– volume: 45
  start-page: 588
  year: 2021
  ident: B5
  article-title: Prevalence and risk evaluation of diabetic complications of the foot among adults with type 1 and type 2 diabetes in a large Canadian population (PEDAL study)
  publication-title: Can. J. Diabetes
  doi: 10.1016/j.jcjd.2020.11.011
  contributor:
    fullname: Aronson
SSID ssj0000399364
Score 2.401974
Snippet Despite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a...
Background Despite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated...
BackgroundDespite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1436146
SubjectTerms aquaporin-4
glymphatic system
liquiritin
matrix metalloproteinase-9
painful diabetic neuropathy
Pharmacology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ3JbtswEIaJIqdeiu5VN0yBIpeGiExSC4_dgqCIA6NNgNwEkiJjAY6sxvbBr9Kn7QzpJHZRoJcefJBFWwTnl_iNPfzJ2HvrjC5MGbjyLudKC8ttXQUurDUuaNXqaOI6Pi2Pz9W3i-Jia6svqglL9sBp4A4rG6SzzuVx6ka1hGrkhBV522qc2xMa5XormYrPYJp3S5VWyWAWpg_DMDXk_ykUPhxkGYl3ayaKhv1_o8w_iyW3Zp-jh-zBBhvhY-ruI3bP94_Z_iT5Tq8P4OxuGdXiAPZhcudIvX7Cfp10VPDbLbsezJWf0bJ8REwYDOprNYP0A2znILpb0ibFa8CmP74AtluApaNpZ-nzl3B68n0i-Xg84ZrHdSfIrEBGUNcL7OE8gPm5MgPV9XEFA2XOCPr0dYiacDlbo3zIJRaSh_RTdn709ezzMd9sysCdLPIld94Wgciwdh5RM7gyjDDLLZxAcAi-RjyUufG2tqgOSp4IEMIISU-WtZJePmN7_bz3LxhUVSXxJUYl5phF7bUKpnStQGKV2to2Yx9uAtQMyXujwZyFwtnEcDYUzmYTzox9ohjetiTf7PgGqqnZqKn5l5oy9u5GAQ3eZ_Tnien9fLVoJHntIa1qkbHnSRG3lyLGLLSSGat3tLLTl90zfTeNXt6YjuLQCPnyf_T-FbtPIxJL4NRrtre8Xvk3yExL-zbeHr8BW_MYDw
  priority: 102
  providerName: Directory of Open Access Journals
Title Liquiritin ameliorates painful diabetic neuropathy in SD rats by inhibiting NLRP3-MMP-9-mediated reversal of aquaporin-4 polarity in the glymphatic system
URI https://www.ncbi.nlm.nih.gov/pubmed/39295943
https://www.proquest.com/docview/3106735292
https://pubmed.ncbi.nlm.nih.gov/PMC11408323
https://doaj.org/article/7bf3cbcc042644638f71c2b20dd9392a
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3JbtswEIaJJKdeiu5Vl4AFilwaxjJJLTy2aYOgiAOhTYDcBJIibQG2rHo5-FX6tJ2hrMQueurBB9uUTXh-kd_IM78I-WisVolOPZPOxkwqbpjJM8-4Mdp6JSsVTFxH1-nlrfx-l9wdkLTvhQlF-9bUZ810dtbUk1Bb2c7soK8TGxSjc2B4IAcuBofkEBS6k6OH9Rf33FR2HTKQgamBbycavT-5hIVBpIF2d3ahYNb_L8L8u1ByZ-e5eEIeb5GRfu6m9pQcuOYZOSk6z-nNKb15aKFantITWjy4UW-ek99XNRb71qu6oXrmptiSD3hJWw3aWk9pd_G1tjQ4W-INijcUhv78SmHckhp8NqkNHj-m11c_CsFGo4IpFnpOgFcpmkAtljDDuaf611q3WNPHJG0xawbIx48DzKTj6Qakgw6xtPOPfkFuL77dnF-y7Q0ZmBVJvGLWmcQjFebWAWZ6m_ohZLiJ5QAN3uWAhiLWzuQGlIGJE8KBH0KsRJpL4cRLctTMG_ea0CzLBDz4MIX8Msmdkl6ntuJAq0IZU0XkUx-gsu18N0rIVzCcZQhnieEst-GMyBeM4f1I9MwOL8wX43KrnDIzXlhjbRwgENYdnw0tNzyuKgWUqCPyoVdACecY_nGiGzdfL0uBPntAqopH5FWniPuvQr5MlBQRyfe0sjeX_XdA1sHHu5fxm_8_9C15hL9DKHqT78jRarF274GSVuY4XF04DqfGH1ynGAs
link.rule.ids 230,315,730,783,787,867,888,2109,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1bk9IwFMcz6_qgL95d8RpnnH1xA6VJL3nU1R1UYBhlx33rJCGBjlAqlwf8KH5az0npLuz4og88QFNI23-S36Hn_EvIG22UjFTsmLAmYEKGmuk0cSzUWhknxUh6E9deP-6ci88X0cUBietaGJ-0b3TeLKazZpFPfG5lOTOtOk-sNeidAsMDOYS8dYPchAEbiJ0o3c_AuOrGoqqRgRhMtlw5Uej-GQqYGnjseXdnHfJ2_X9jzOupkjtrz9ld8r3udZVy8qO5Xumm-XXN0PHfD-seubPFUfqu2n6fHNjiATkeVH7WmxM6vCrPWp7QYzq4crrePCS_uzkmEuervKBqZqdY7g_oSksFul1PafXHbm6od83Ehx9vKDT99oFCuyXV-G6Sa9x_TPvdrwPOer0Bk8zXswALUzSYWiyhh3NH1c-1KjFfkAlaYkQOAQR-HSAsHU83IEt0n6WVN_Ujcn72cXjaYduHPTDDo2DFjNWRQ-JMjQWEdSZ2bYieIxMCkDibAnbyQFmdalAdBmUIHq4NJ4zHqeCWPyaHxbywTwhNkoTDK2zHELtGqZXCqdiMQiBhLrUeNcjb-tJnZeXpkUEshELJvFAyFEq2FUqDvEd1XLZEP27_wXwxzraXL0u040YbE3jAhDnNJW0T6jAYjSQQqGqQ17W2Mhi_eFNGFXa-XmYcPfyAgmXYIEeV1i5_Ctk1koI3SLqnwr2-7G8BbXmP8FpLT_9_11fkVmfY62bdT_0vz8htPCc-uU48J4erxdq-ABpb6Zd-6P0Bo045Mw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1bb9MwFMctGBLihXEd5WoktBeWNo2dix9hoxrQVhFs0iQeItux24g2zXp5KB-FT8s5Trq1E0976EMaJ3GSv-3fSY7_IeSD0lKEMrIeN9r3uAiUp5LYeoFSUlvBc-FMXAfD6PScf7sIL5qsykWTVllqVbTLybRdFmOXW1lNdWeTJ9ZJB8fA8EAOAetUue3cJfeg0frRVqTuemEceSNez5OBOEx0bDWW6AAacOgeWOSYd2sscpb9_-PMm-mSW-NPb5_82tS8Tjv53V4tVVv_uWHqeLtTe0QeNlhKP9VlHpM7pnxCDtPa13p9RM-up2ktjughTa8dr9dPyd9-gQnFxbIoqZyaCU77B4SllQT9ria0fsBbaOrcM_EjyGsKRX-eUCi3oAqXxoXC7Ud02P-RMm8wSD3huXktwMQUjabmC6jhzFJ5uZIV5g16nFYYmUMggbsDlKWjyRrkiS60tPaofkbOe1_Ojk-95qMPnmahv_S0UaFF8ky0AZS1OrJdiKJDHQCYWJMAfjJfGpUoUB8GZwggtgsXjUUJZ4Y9J3vlrDQvCI3jmMEv6EYQw4aJEdzKSOcBEDETSuUt8nFz-7Oq9vbIICZCsWROLBmKJWvE0iKfUSFXJdGX2_0xm4-y5hZmsbJMK619B5rQt9m4qwMV-HkugERli7zf6CuDdowvZ2RpZqtFxtDLD2hYBC1yUOvt6lDIsKHgrEWSHSXu1GV3DejLeYVv9PTy9pu-I_fTk17W_zr8_oo8wEvicuz4a7K3nK_MG4CypXrrWt8_SJo7sw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Liquiritin+ameliorates+painful+diabetic+neuropathy+in+SD+rats+by+inhibiting+NLRP3-MMP-9-mediated+reversal+of+aquaporin-4+polarity+in+the+glymphatic+system&rft.jtitle=Frontiers+in+pharmacology&rft.au=Jia%2C+Shuai-Ying&rft.au=Yin%2C+Wen-Qin&rft.au=Xu%2C+Wen-Mei&rft.au=Li%2C+Jiang&rft.date=2024-09-04&rft.issn=1663-9812&rft.eissn=1663-9812&rft.volume=15&rft.spage=1436146&rft_id=info:doi/10.3389%2Ffphar.2024.1436146&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon